141 related articles for article (PubMed ID: 8074496)
1. African Burkitt's lymphoma: a plant, Euphorbia tirucalli, reduces Epstein-Barr virus-specific cellular immunity.
Imai S; Sugiura M; Mizuno F; Ohigashi H; Koshimizu K; Chiba S; Osato T
Anticancer Res; 1994; 14(3A):933-6. PubMed ID: 8074496
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-enhancing plant promoters in east Africa.
Mizuno F; Osato T; Imai S; Koizumi S; Aya T; Kinoshita T; Hirai N; Hirota M; Ohigashi H; Koshimizu K
AIDS Res; 1986 Dec; 2 Suppl 1():S151-5. PubMed ID: 3030344
[TBL] [Abstract][Full Text] [Related]
3. Cryptic dysfunction of cellular immunity in asymptomatic human immunodeficiency virus (HIV) carriers and its actualization by an environmental immunosuppressive factor.
Sugiura M; Imai S; Sakurada K; Miyazaki T; Osato T
In Vivo; 1994; 8(6):1019-22. PubMed ID: 7772730
[TBL] [Abstract][Full Text] [Related]
4. Chromosome translocation and c-MYC activation by Epstein-Barr virus and Euphorbia tirucalli in B lymphocytes.
Aya T; Kinoshita T; Imai S; Koizumi S; Mizuno F; Osato T; Satoh C; Oikawa T; Kuzumaki N; Ohigashi H
Lancet; 1991 May; 337(8751):1190. PubMed ID: 1673740
[TBL] [Abstract][Full Text] [Related]
5. Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt's lymphoma.
Rooney CM; Rickinson AB; Moss DJ; Lenoir GM; Epstein MA
IARC Sci Publ; 1985; (60):249-64. PubMed ID: 2998992
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus and Burkitt's lymphoma worldwide: the causal relationship revisited.
de-Thé G
IARC Sci Publ; 1985; (60):165-76. PubMed ID: 2998987
[TBL] [Abstract][Full Text] [Related]
7. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development.
Jondal M; Gunven P
Clin Exp Immunol; 1977 Jul; 29(1):11-5. PubMed ID: 70292
[TBL] [Abstract][Full Text] [Related]
8. The etiology of Burkitt's lymphoma and the history of the shaken dogmas.
de Thé G
Blood Cells; 1993; 19(3):667-73; discussion 674-5. PubMed ID: 8018947
[TBL] [Abstract][Full Text] [Related]
9. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
[TBL] [Abstract][Full Text] [Related]
10. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
Okugawa K; Itoh T; Kawashima I; Takesako K; Mazda O; Nukaya I; Yano Y; Yamamoto Y; Yamagishi H; Ueda Y
Oncol Rep; 2004 Oct; 12(4):725-31. PubMed ID: 15375491
[TBL] [Abstract][Full Text] [Related]
11. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
12. Is endemic Burkitt's lymphoma an alliance between three infections and a tumour promoter?
van den Bosch CA
Lancet Oncol; 2004 Dec; 5(12):738-46. PubMed ID: 15581545
[TBL] [Abstract][Full Text] [Related]
13. The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis.
Niller HH; Salamon D; Ilg K; Koroknai A; Banati F; Bauml G; Rucker O; Schwarzmann F; Wolf H; Minarovits J
Med Sci Monit; 2003 Jan; 9(1):HY1-9. PubMed ID: 12552250
[TBL] [Abstract][Full Text] [Related]
14. Squamous-cell carcinoma, Kaposi's sarcoma and Burkitt's lymphoma are consequences of impaired immune surveillance of ubiquitous viruses in acquired immune deficiency syndrome, allograft recipients and tropical African patients.
Purtilo DT; Manolov G; Manolova Y; Harada S; Lipscomb H
IARC Sci Publ; 1984; (63):749-70. PubMed ID: 6100288
[TBL] [Abstract][Full Text] [Related]
15. MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.
Staege MS; Lee SP; Frisan T; Mautner J; Scholz S; Pajic A; Rickinson AB; Masucci MG; Polack A; Bornkamm GW
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4550-5. PubMed ID: 11917131
[TBL] [Abstract][Full Text] [Related]
16. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines.
Röth A; Pfaff P; Lange W; Finke J
Cytokines Mol Ther; 1996 Mar; 2(1):21-8. PubMed ID: 9384686
[TBL] [Abstract][Full Text] [Related]
17. EBV-B cell interactions: immortalization, rescue from apoptosis, tumorigenicity (a short review).
Klein G
Acta Microbiol Immunol Hung; 1996; 43(2-3):97-105. PubMed ID: 8876725
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
19. The frequency of Epstein-Barr virus infection and Burkitt's lymphoma at high and low altitudes in East Africa.
Geser A; Brubaker G; Olwit GW
Rev Epidemiol Sante Publique; 1980 Oct; 28(3):307-21. PubMed ID: 6258200
[TBL] [Abstract][Full Text] [Related]
20. [Epstein-Barr virus and Burkitt's lymphoma].
Joab I
Med Trop (Mars); 1999; 59(4 Pt 2):499-502. PubMed ID: 10901854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
